Corvus Pharmaceuticals, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Corvus Pharmaceuticals, Inc. (CRVS) had Common Stock, Capital Shares Reserved for Future Issuance of 28.36 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 28.36M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 28.39M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 25.71M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 25.73M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 28.36M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 28.39M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 25.71M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 25.73M shares 10-Q · filed 2025-11-04 | |
| 2025-06-30 | 25.89M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 33.55M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 31.11M shares 10-K · filed 2026-03-12 | |
| 2024-09-30 | 36.43M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 36.46M shares 10-Q · filed 2024-08-06 | |
| 2024-03-31 | 15.22M shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 13.26M shares 10-K · filed 2026-03-12 | |
| 2023-09-30 | 13.26M shares 10-Q · filed 2023-11-07 | |
| 2023-06-30 | 13.27M shares 10-Q · filed 2023-08-08 | |
| 2023-03-31 | 13.27M shares 10-Q · filed 2023-05-08 | |
| 2022-12-31 | 11.42M shares 10-K · filed 2025-03-25 | |
| 2022-09-30 | 11.42M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 11.42M shares 10-Q · filed 2022-08-08 | |
| 2022-03-31 | 11.42M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 9.56M shares 10-K · filed 2024-03-19 | |
| 2021-09-30 | 9.57M shares 10-Q · filed 2021-11-01 | |
| 2021-06-30 | 11.35M shares 10-Q · filed 2021-08-02 | |
| 2021-03-31 | 11.35M shares 10-Q · filed 2021-04-29 | |
| 2020-12-31 | 10.21M shares 10-K · filed 2023-03-28 | |
| 2020-09-30 | 10.22M shares 10-Q · filed 2020-10-29 | |
| 2020-06-30 | 10.24M shares 10-Q · filed 2020-07-30 | |
| 2020-03-31 | 10.32M shares 10-Q · filed 2020-04-30 | |
| 2019-12-31 | 9.21M shares 10-K · filed 2022-03-10 | |
| 2019-09-30 | 7.75M shares 10-Q · filed 2019-10-29 | |
| 2019-06-30 | 7.82M shares 10-Q · filed 2019-08-01 | |
| 2019-03-31 | 7.86M shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 6.71M shares 10-K · filed 2021-03-25 | |
| 2018-09-30 | 6.81M shares 10-Q · filed 2018-11-01 | |
| 2018-06-30 | 6.96M shares 10-Q · filed 2018-08-02 | |
| 2018-03-31 | 7.05M shares 10-Q · filed 2018-05-03 | |
| 2017-12-31 | 6.31M shares 10-K · filed 2020-03-09 | 6.11M shares 10-K · filed 2018-03-01 |
| 2017-09-30 | 6.42M shares 10-Q · filed 2017-11-02 | |
| 2017-06-30 | 6.51M shares 10-Q · filed 2017-08-03 | |
| 2017-03-31 | 6.58M shares 10-Q · filed 2017-05-04 | |
| 2016-12-31 | 5.64M shares 10-K · filed 2019-03-07 | |
| 2016-09-30 | 5.72M shares 10-Q · filed 2016-11-03 | |
| 2016-06-30 | 5.81M shares 10-Q · filed 2016-08-04 | |
| 2016-03-31 | 5.88M shares 10-Q · filed 2016-05-05 | |
| 2015-12-31 | 18.54M shares 10-K · filed 2018-03-01 | |
| 2014-12-31 | 10.56M shares 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |